| Pharmaceutical active ingredients: |
| Amiloride HydrochlorideCyclopenthiazide |
| Available forms, composition and doses of Navispare: |
| Tablets; Oral; Amiloride Hydrochloride 2.5 mg; Cyclopenthiazide 0.25 mg |
| Navispare medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03EA07 - Cyclopenthiazide and potassium-sparing agents |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisGoldshield PharmaceuticalsZuellig Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tensoflux | Amiloride Hydrochloride; Bendroflumethiazide | Hennig Arzneimittel |
| Buram | Amiloride Hydrochloride; Bumetanide | Leo Pharma |
| Burinex A | Amiloride Hydrochloride; Bumetanide | Leo Pharma |
| Amicloton | Amiloride Hydrochloride; Chlorthalidone | Zentiva |
| Diupress | Amiloride Hydrochloride; Chlorthalidone | Eurofarma Laboratorios |
| Amifru | Amiloride Hydrochloride; Furosemide | Elder Pharmaceuticals |
| Aridil | Amiloride Hydrochloride; Furosemide | Wockhardt |
| Diaphal | Amiloride Hydrochloride; Furosemide | Pierre Fabre |
| Diflux | Amiloride Hydrochloride; Furosemide | Quesada Farmaceutica |
| Diurisa | Amiloride Hydrochloride; Furosemide | Eurofarma Laboratorios |